A54145 is a complex of acidic lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18158, NRRL 18159, and NRRL 18160. Each antibiotic factor consists of a peptide core bearing an N-terminal acyl substituent. N-Lys-tert-BOC-protected A54145 complex was deacylated by Actinoplanes utahensis; three protected core peptides were isolated. A54145 antibiotic analogs were synthesized by acylation of the tryptophan N-terminus with 2,4,5-trichlorophenyl active esters, followed by deblocking with trifluoroacetic acid.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7164/antibiotics.43.601 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of protein interaction surface on fatty acyl selectivity of starter condensation domain in lipopeptide biosynthesis.
Appl Microbiol Biotechnol
January 2020
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Lipopeptides are important non-ribosomal peptide synthetases (NRPSs) products with broad therapeutic potential in biotechnology and biopharmaceutical applications. Fatty acyl modifications in N-terminal of lipopeptides have attracted wide interest in the engineering processes of altered fatty acyl selectivity. In this study, we focused on the starter condensation domain of antibiotic A54145 (lptC1) and its indiscriminate selectivity of fatty acyl substrates, which results in multi-component products.
View Article and Find Full Text PDFSynthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: a perspective.
J Ind Microbiol Biotechnol
July 2018
CognoGen Biotechnology Consulting, 7636 Andora Drive, Sarasota, FL, 34238, USA.
Combinatorial biosynthesis of novel secondary metabolites derived from nonribosomal peptide synthetases (NRPSs) has been in slow development for about a quarter of a century. Progress has been hampered by the complexity of the giant multimodular multienzymes. More recently, advances have been made on understanding the chemical and structural biology of these complex megaenzymes, and on learning the design rules for engineering functional hybrid enzymes.
View Article and Find Full Text PDFProduction of novel lipopeptide antibiotics related to A54145 by Streptomyces fradiae mutants blocked in biosynthesis of modified amino acids and assignment of lptJ, lptK and lptL gene functions.
J Antibiot (Tokyo)
January 2011
Cubist Pharmaceuticals, Lexington, MA 02421, USA.
A54145 is a complex of lipopeptide antibiotics produced by Streptomyces fradiae. A54145 factors are structurally related to daptomycin, with four modified amino acids, only one of which is present in daptomycin. We generated three mutants defective in lptJ, lptK or lptL, whose gene products are involved in the formation of hydroxy-Asn(3) (hAsn(3)) and methoxy-Asp(9) (moAsp(9)).
View Article and Find Full Text PDFThe lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.
J Ind Microbiol Biotechnol
February 2006
Cubist Pharmaceuticals Inc., 65 Hayden Av., Lexington, MA, 02421, USA.
Ca(2+)-dependent cyclic lipodepsipeptides are an emerging class of antibiotics for the treatment of infections caused by Gram-positive pathogens. These compounds are synthesized by nonribosomal peptide synthetase (NRPS) complexes encoded by large gene clusters. The gene cluster encoding biosynthetic pathway enzymes for the Streptomyces fradiae A54145 NRP was cloned from a cosmid library and characterized.
View Article and Find Full Text PDFA54145 a new lipopeptide antibiotic complex: microbiological evaluation.
J Antibiot (Tokyo)
June 1990
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
A54145 complex is made up of eight factors; A, A1, B, B1, C, D, E, and F which were active in vitro (MIC 0.25 approximately greater than 32 micrograms/ml) against Gram-positive aerobic organisms. The complex, factor B and B1 were found to be active against two strains of Clostridium perfringens.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!